Adn-388 !exclusive! Jun 2026
Several clinical trials have been initiated to investigate the safety and efficacy of ADN-388 in patients with various types of cancer. These trials aim to establish the optimal dosing regimen, evaluate the pharmacokinetics and pharmacodynamics of ADN-388, and assess its antitumor activity.